GlassScriptPhysician profile
Tucker Lee Johnson
NPI 1376115865
$2,411.89
in general payments reported to CMS, 2019-2025
19 companies · $804 in 2025
The $804 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $281 · 2023: $894 · 2024: $433 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,130.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $991.11 | 2022-2025 | Lifevest |
| Philips North America LLC | $284.48 | 2023-2025 | Diagnostic Ecg Service |
| Inari Medical, INC. | $169.33 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $148.32 | 2022-2023 | Camzyos |
| Medtronic, INC. | $141.19 | 2025 | Cobalt Dr Mri Surescan |
| Abiomed | $136.40 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.98 | 2023 | Jardiance |
| Bridgebio Pharma, INC. | $115.32 | 2025 | Attruby |
| Pfizer INC. | $53.87 | 2023-2025 | |
| Boston Scientific Corporation | $48.00 | 2022-2023 | Avvigo Guidance System |
| Takeda Pharmaceuticals U.S.A., INC. | $29.49 | 2025 | Ninlaro |
| Heartflow, INC. | $29.25 | 2023 | Ffrct |
| Progenics Pharmaceuticals, INC. | $25.93 | 2024 | |
| Alnylam Pharmaceuticals INC. | $24.67 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $21.99 | 2025 | Lynparza, Keytruda |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $19.26 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.67 | 2025 | |
| Servier Pharmaceuticals LLC | $15.88 | 2024 | |
| Daiichi Sankyo INC. | $14.75 | 2025 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tucker Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.